Patent details

Basic Information

Publication number:

EP1642972

PCT Application Number:

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP050189844

PCT Publication Number:

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

Therapeutic uses of BR43X2 soluble receptors

French Title of Invention:

Procédés d'utilisation thérapeutique des récepteurs solubles BR43x2

German Title of Invention:

Verfahren zur therapeutischen Verwendung von löslichen rezeptoren BR43X2

SPC Number:

Dates

Filing date:

07/01/2000

Grant date:

30/12/2009

EP Publication Date:

30/12/2009

PCT Publication Date:

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

05/04/2006

EP B1 Publication Date:

30/12/2009

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

07/01/2018

Expiration date:

07/01/2020

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

07/01/2000

 

 

Name:

ZymoGenetics Inc.

Address:

1201 Eastlake Avenue East, Seattle, WA 98102, United States (US)

Agent

Name:

OFFICE FREYLINGER S.A.

From:

24/02/2010

Address:

Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)

To:

Inventor

1

Name:

Madden Karen

Address:

United States (US)

2

Name:

Xu Wenfeng

Address:

United States (US)

3

Name:

Yee David P.

Address:

United States (US)

4

Name:

Gross Jane A.

Address:

United States (US)

Priority

Priority Number:

226533

Priority Date:

12/04/1994

Priority Country:

United States (US)

Classification

Main IPC Class:

C12N 15/11;

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

24/12/2016

Last Annual Fee Paid Number:

18

Last Annual Fee Paid Amount:

262 Euro

Payer:

MARKS & CLERK LLP

Filing date	Document type	Number of pages
31/05/2018	Outgoing Correspondence	1